Familial hypertrophic cardiomyopathy: functional variance among individual cardiomyocytes as a trigger of FHC-phenotype development
Open Access
- 10 October 2014
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 5, 392
Abstract
Familial hypertrophic cardiomyopathy (FHC) is the most frequent inherited cardiac disease. It has been related to numerous mutations in many sarcomeric and even some non-sarcomeric proteins. So far, however, no common mechanism has been identified by which the many different mutations in different sarcomeric and non-sarcomeric proteins trigger development of the FHC phenotype. Here we show for different MYH7 mutations variance in force pCa-relations from normal to highly abnormal as a feature common to all mutations we studied, while direct functional effects of the different FHC-mutations, e.g., on force generation, ATPase or calcium sensitivity of the contractile system, can be quite different. The functional variation among individual M. soleus fibers of FHC-patients is accompanied by large variation in mutant vs. wildtype β-MyHC-mRNA. Preliminary results show a similar variation in mutant vs. wildtype β-MyHC-mRNA among individual cardiomyocytes. We discuss our previously proposed concept as to how different mutations in the β-MyHC and possibly other sarcomeric and non-sarcomeric proteins may initiate an FHC-phenotype by functional variation among individual cardiomyocytes that results in structural distortions within the myocardium, leading to cellular and myofibrillar disarray. In addition, distortions can activate stretch-sensitive signalling in cardiomyocytes and non-myocyte cells which is known to induce cardiac remodelling with interstitial fibrosis and hypertrophy. Such a mechanism will have major implications for therapeutic strategies to prevent FHC-development, e.g., by reducing functional imbalances among individual cardiomyocytes or by inhibition of their triggering of signalling paths initiating remodelling. Targeting increased or decreased contractile function would require selective targeting of mutant or wildtype protein to reduce functional imbalances.Keywords
This publication has 50 references indexed in Scilit:
- Unequal allelic expression of wild-type and mutated β-myosin in familial hypertrophic cardiomyopathyBasic Research in Cardiology, 2011
- Normal passive viscoelasticity but abnormal myofibrillar force generation in human hypertrophic cardiomyopathyJournal of Molecular and Cellular Cardiology, 2010
- Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-βJournal of Clinical Investigation, 2010
- Myocardial Fibrosis as an Early Manifestation of Hypertrophic CardiomyopathyNew England Journal of Medicine, 2010
- Microarchitecture Is Severely Compromised but Motor Protein Function Is Preserved in Dystrophic mdx Skeletal MuscleBiophysical Journal, 2010
- Temporal and mutation-specific alterations in Ca2+ homeostasis differentially determine the progression of cTnT-related cardiomyopathies in murine modelsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Cardiomyopathy Mutations Reveal Variable Region of Myosin Converter as Major Element of Cross-Bridge ComplianceBiophysical Journal, 2009
- Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in miceJournal of Clinical Investigation, 2008
- Single-Molecule Measurement of the Stiffness of the Rigor Myosin HeadBiophysical Journal, 2008
- Stiffness and Fraction of Myosin Motors Responsible for Active Force in Permeabilized Muscle Fibers from Rabbit PsoasBiophysical Journal, 2007